Competing interests
The following are potential conflicts of interest (within last 4 years) for the guideline panel members and authors of this work.
Kangmo Ahn; declares no competing interest related to this guideline.
Suleiman Al-Hammadi; received honoraria for speakers bureau, giving talks, and sponsorship at meetings from Danone Nutrition.
Kirsten Beyer; consult as technical advisor for DuPont, Unilever and Danone.
Jan Brożek; received research support from WAO for development of DRACMA and GLAD-P guidelines
Wesley Burks (not present during the meeting); current consulting agreements with: Dynavax Technologies Corp., Genalyte, GLG Research, Perrigo Company, Regeneron Pharmaceuticals, NIH Grant support c. Abbott Laboratories, Levine’s Children’s Hospital, Mylan Speciality, Perosphere, Inc. Past consulting agreements: ActoGeniX, Curalogic, Dow AgroSciences, ExploraMed Development, McNeill Nutritionals, Merck, Novartis Pharma AG, Sanofi-Aventis US, Schering Plough, Unilver.
Giorgio Walter Canonica (not present); declares no competing interest related to this guideline.
Carlos Cuello-García; declares no competing interest related to prebiotics. Part of his PhD scholarship and travel support for meetings is supported by WAO.
Motohiro Ebisawa (not present during the meeting); declares no competing interest related to this guideline.
Alessandro Fiocchi; received research support from Danone. Has received travel support for meetings for presentation of DRACMA guidelines in South East Asia from Danone Malaysia, and support for travel and honorarium for speaking from Ordesa Group.
Rose Kamenwa; declares no competing interest related to this guideline.
Bee Wah Lee (not present during meeting); received research support from Abbott Nutrition, Danone Nutrition, Nestle Nutrition Honoraria for speakers bureau, giving talks, sponsorship at meetings.
Haiqi Li (not present during meeting); declares no conflicts of interest related to this guideline.
Ruby Pawankar; received support from Danone Asia Pacific for act as a speaker at a Food allergy Asia Pacific symposium 2012.
Susan Prescott; Advisory Board - Nestle Nutrition Institute (Australasia), Advisory Board for Danone (Asia Pacific), investigator initiated trial for which Danone provided prebiotic.
John Riva; declares no competing interest related to this guideline.
Lanny Rosenwasser; received research Grant from Novartis /Genentech Roche (finished in 2011). Advisory board and speakers board for Astra Zeneca and Novartis/Genentech (last applicable in 2012), 5 patents on the biology of IL-1 and it’s uses.
Hugh Sampson; Consultant– Danone Research for Specialized Nutrition Scientific Advisory Committee.
Holger Schünemann; received research support from WAO for development of DRACMA and GLAD-P guidelines Travel support from WAO.
Michael D. Spigler (not present during meeting); declares no competing interest related to this guideline.
Luigi Terracciano (not present during meeting); Heinz-Plada Italy Medical consultant for website. Travel support from World Allergy Organization.
Andrea Vereda; declares no competing interest related to this guideline.
Susan Waserman; declares no competing interest related to this guideline.
Juan José Yepes Nuñez; declares no competing interest related to this guideline. Part of scholarship paid by WAO funding received by HJS and JLB for developing these guidelines.
Yuan Zhang; declares no competing interest.
Gian Paolo Morgano; declares no competing interest.
Arnav Agarwal; declares no competing interest.
Shreyas Gandhi; declares no competing interest.
Authors’ contributions
CACG was involved in the initial concept and methodological design of the guideline. Conducted the acquisition of data, analyses, and interpretation; drafted the article and modified according to substantial feedback from the guideline panel members (authors). AF as Chair of the Guideline Panel, directed and organized guideline panel meetings, was involved in the initial concept and methodological design of the guideline, conducted data interpretation, and provided substantial feedback on the drafted manuscript. RP as Chair of the Guideline Panel, directed and organized guideline panel meetings, was involved in the initial concept and methodological design of the guideline, conducted data interpretation, and provided substantial feedback on the drafted manuscript. JJYN was involved in the methodological design of the guideline, conducted the acquisition of data, analyses, and interpretation; contributed in drafting the article and modified according to substantial feedback from the guideline panel members (authors). GPM conducted data acquisition, analyses, and interpretation; provided significant feedback for the draft of the guideline. YZ conducted data acquisition, analyses, and interpretation; provided significant feedback for the draft of the guideline. KA was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. SAH was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. AA conducted data acquisition, analyses, and interpretation; provided significant feedback for the draft of the guideline. SG conducted data acquisition, analyses, and interpretation; provided significant feedback for the draft of the guideline. KB was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. WB was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. GWC was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. ME was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. RK was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. BWL was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. HL was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. SP was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. JJR was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. LR was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. HS was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. MS was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. LT was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. AV was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. SW was involved in the analysis and interpretation of the evidence, drafting of the recommendations, and provided significant feedback for the final manuscript. HJS as Chair of the Guideline Panel and principal investigator chaired and organized guideline panel meetings, ensured conflicts of interest were managed, obtained consensus on strength, direction and wording of the final recommendations, developed the initial concept and methodological design of the guideline, conducted data interpretation, and provided substantial feedback on the drafted manuscript. JLB directed and organized guideline panel meetings and the methodologist team; was involved in the initial concept and methodological design of the guideline, conducted data acquisition and interpretation, and helped writing the final manuscript. All authors read and approved the final manuscript.